155 related articles for article (PubMed ID: 20509277)
1. [Correlation between atherosclerosis--coronary disease and insulin resistance, regarded as the basis of metabolic syndrome].
Mihalcea C; Pandele GI
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):59-68. PubMed ID: 20509277
[TBL] [Abstract][Full Text] [Related]
2. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters.
Bulum T; Duvnjak L
Acta Clin Croat; 2013 Mar; 52(1):43-51. PubMed ID: 23837272
[TBL] [Abstract][Full Text] [Related]
4. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
5. Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.
Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Goodarzi MO; Stefanovski D; Norris JM; Rewers MJ; Hanley AJ
Diabetes Obes Metab; 2013 May; 15(5):441-7. PubMed ID: 23216702
[TBL] [Abstract][Full Text] [Related]
6. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients.
Rocha M; Bañuls C; Bellod L; Rovira-Llopis S; Morillas C; Solá E; Víctor VM; Hernández-Mijares A
PLoS One; 2013; 8(11):e78670. PubMed ID: 24223837
[TBL] [Abstract][Full Text] [Related]
7. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes.
Thai PV; Tien HA; Van Minh H; Valensi P
Cardiovasc Diabetol; 2020 Sep; 19(1):137. PubMed ID: 32919465
[TBL] [Abstract][Full Text] [Related]
9. Association of serum uric acid and metabolic syndrome in type 2 diabetes.
Bonakdaran S; Kharaqani B
Curr Diabetes Rev; 2014 Mar; 10(2):113-7. PubMed ID: 24588601
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, insulin resistance, and atherosclerosis in Japanese type 2 diabetic patients.
Taniguchi A; Fukushima M; Kuroe A; Sakaguchi K; Hashimoto H; Yoshioka I; Kitatani N; Tsuji T; Ohya M; Ohgushi M; Nagasaka S; Isogai O; Nakai Y; Inagaki N; Seino Y
Metabolism; 2007 Aug; 56(8):1099-103. PubMed ID: 17618956
[TBL] [Abstract][Full Text] [Related]
11. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
[TBL] [Abstract][Full Text] [Related]
12. The metabolic basis of atherogenic dyslipidemia.
Vinik AI
Clin Cornerstone; 2005; 7(2-3):27-35. PubMed ID: 16473258
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
16. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
[TBL] [Abstract][Full Text] [Related]
17. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
[TBL] [Abstract][Full Text] [Related]
18. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans.
Young KA; Maturu A; Lorenzo C; Langefeld CD; Wagenknecht LE; Chen YI; Taylor KD; Rotter JI; Norris JM; Rasouli N
J Diabetes Complications; 2019 Feb; 33(2):118-122. PubMed ID: 30522790
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Huţanaşu IC; Ungureanu D; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):692-9. PubMed ID: 23272512
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease.
Matsumoto K; Kizaki Y; Fukae S; Tomihira M; Sera Y; Ueki Y; Tominaga T; Miyake S
Diabetes Res Clin Pract; 2001 Mar; 51(3):181-6. PubMed ID: 11269890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
